Birketts advises Foresight on investment into Clearview Endoscopy Ltd
16 October 2023
Birketts has advised Foresight Group on its £6 million investment into Clearview Endoscopy Limited.
Foresight Group is a sustainability-led alternative assets and SME investment manager. The company manages £12.2 billion for some of the world’s largest institutional investors, private and high net-worth individuals. In 2019, Foresight launched it £100m East of England Fund with the aim of investing into established companies with a view to developing management and deliver a growth strategy.
Clearview works with NHS trusts and private clinics to proactively limit endoscopy down times through fast and reliable repairs combined with a broad endoscope temporary lending offering. As the number of endoscopies increases year on year with the growing clinical focus on minimally invasive procedures and early diagnosis of diseases like bowel cancer, Clearview’s services help to reduce waiting lists in NHS trusts, allowing clinicians to detect and treat issues as early as possible.
Foresight’s investment will enable to appointment of a new management team and will accelerate Clearview’s growth. The buyout is being led by Darren Likely, previously Managing Director of Agar Scientific, who will join as CEO. The investment will also enable to company to expand its service offering while creating high quality jobs across the East of England.
The Birketts team was co-led by Corporate Partners Ed Savory and Adam Jones. They were supported by: Macauley Alsford (Corporate), Arwa Salman (Corporate), Harry Close (Corporate), Matthew Grindley (Commercial Property), Ben Lewins (Employment), Robbie Watson (Corporate Tax), Georgina Perrott (Commercial and Technology), Devreaux Gravell (Banking and Finance), Lottie Fletcher (Banking and Finance) and Maisie Lee (Banking and Finance).
Commenting on the deal, Ed Savory said: “Birketts is proud to have worked with Foresight on the latest investment from its East of England fund. It has been a pleasure working alongside the team, led by Chris Wardle and Nick Mettyear, and we look forward to seeing their future success with Clearview Endoscopy.”
Adam Jones, head of Private Equity at Birketts added: “It has been great to advise Foresight on another transaction and support their ongoing appetite for investing in the region. This deal demonstrates our private equity expertise which continues to have a strong reputation.”
Chris Wardle from Foresight Group LLP said: “Clearview is a leader in its market with an excellent reputation amongst its customers for high quality service. Our thanks goes to the Birketts team for helping us to navigate this deal and ensure the company’s continued success.”
-
Ed Savory
-
Adam Jones
-
Macauley Alsford-White
-
Arwa Salman
-
Harry Close
-
Matthew Grindley
-
Benjamin Lewins
-
Robbie Watson
-
Georgina Perrott
-
Devreaux Gravell
-
Lottie Fletcher
-
Maisie Lee
